MP68-12 OUR EARLY CLINICAL EXPERIENCE WITH MANTRA TM MULTI ARM SURGICAL ROBOTIC SYSTEM (SS INNOVATIONS GROUP COMPANY) IN MAJOR URO-ONCOLOGICAL SURGERIES

Abstract

You have accessJournal of UrologyCME1 Apr 2023MP68-12 OUR EARLY CLINICAL EXPERIENCE WITH MANTRATM MULTI ARM SURGICAL ROBOTIC SYSTEM (SS INNOVATIONS GROUP COMPANY) IN MAJOR URO-ONCOLOGICAL SURGERIES Amitabh Singh, Ashish Khanna, Sarbartha Kumar Pratihar, Vivek Vasudev, Nikhil Saurabh, and Sudhir Rawal Amitabh SinghAmitabh Singh More articles by this author , Ashish KhannaAshish Khanna More articles by this author , Sarbartha Kumar PratiharSarbartha Kumar Pratihar More articles by this author , Vivek VasudevVivek Vasudev More articles by this author , Nikhil SaurabhNikhil Saurabh More articles by this author , and Sudhir RawalSudhir Rawal More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003331.12AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: SSI MantraTM is a new addition to the arsenal of robotics systems in India for clinical usage. Here, we provide the initial outcomes of patients undergoing different types of major uro-oncological procedures. METHODS: A total of 32 patients affected by various urological conditions like prostate cancer, renal cancer, bladder cancer, and vesicovaginal fistula underwent treatment with SSI MantraTM system. Study was approved by institutional board (IRB No- 765/SO/SKR-35). Clinical use of MantraTM was registered with national clinical trial registry (CTRI/2020/11/029053). This system has four independent Arms which are docked. Demography of patient and clinical outcome like docking time, console time, total operative time, complications like bleeding, bowel injury, urinary incontinence, conversion to open, total hospital stay and perioperative outcomes were reported. RESULTS: A total of thirty–two patients were included in this study. This includes radical prostatectomy (n=15), radical cystectomy with ileal conduit (n=6), radical cystectomy with neo-bladder(n=4), radical nephrectomy (n=3), partial nephrectomy (n=2), partial cystectomy (n=1) and vesico-vaginal fistula repair (n=1). Mean age, BMI, ASA, draping time, patients positioning time, arm cart positioning, docking time, surgeon console time, total surgery time, undock time of radical prostatectomy and radical cystectomy patient was 66.1 vs 57.3 yrs , 26.1 vs 22.3, 3.3 vs 2.66, 19.3 vs 13.4 mins, 3.2 vs 5.66 mins, 13.8 vs 12.7 mins 7.2 vs 5.8 mins, 3hrs 12 min vs 5 hrs 20 mins, 5 hrs 6 mins vs 6 hrs 10 min, 10.9 vs 10.2 min respectively. There were total three conversions to open (radical prostatectomy (n=1), radical nephrectomy (n=1) and radical cystectomy with ileal conduit (n=1). CONCLUSIONS: Our experience with SSI MANTRA platform confirms that it is a robust, safe and efficient platform for all major urooncological procedures and it would expand the reach of robotic platform. Source of Funding: None © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 209Issue Supplement 4April 2023Page: e957 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Amitabh Singh More articles by this author Ashish Khanna More articles by this author Sarbartha Kumar Pratihar More articles by this author Vivek Vasudev More articles by this author Nikhil Saurabh More articles by this author Sudhir Rawal More articles by this author Expand All Advertisement PDF downloadLoading ...